Screener
Charles River Laboratories CRL Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Other income (expense) | ||||
| Interest income | 1,032 | 1,097 | 2,065 | 2,501 |
| Interest expense | (30,340) | (29,967) | (57,082) | (57,851) |
| Other (expense) income, net | (37,410) | 154 | (161,540) | (12,057) |
| Income before income taxes | 53,170 | 71,418 | 23,228 | 107,396 |
| Provision for income taxes | 53,930 | 18,725 | 38,790 | 28,825 |
| Net income (loss) | (760) | 52,693 | (15,562) | 78,571 |
| Less: Net income attributable to noncontrolling interests | 722 | 367 | 763 | 776 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's other income, net (note 6)?
- Charles River Laboratories (CRL) reported other income, net (note 6) of -$37.41M in Q2 2026.
- How has Charles River Laboratories's other income, net (note 6) changed year-over-year?
- Charles River Laboratories's other income, net (note 6) decreased by 24392.2% year-over-year, from $154K to -$37.41M.
- What is the long-term trend for Charles River Laboratories's other income, net (note 6)?
- Over 3 years (2021 to 2024), Charles River Laboratories's other income, net (note 6) has grown at a -24.2% compound annual growth rate (CAGR), from -$37.97M to -$16.52M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.
Ask your AI about Charles River Laboratories's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude